AdvanSix (ASIX) to Release Quarterly Earnings on Friday

AdvanSix (NYSE:ASIX) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, May 3rd. Analysts expect the company to announce earnings of ($0.66) per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

AdvanSix (NYSE:ASIX) last released its quarterly earnings results on Friday, February 16th. The company reported ($0.17) EPS for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.02. AdvanSix had a net margin of 3.56% and a return on equity of 6.98%. The business had revenue of $382.21 million for the quarter, compared to analyst estimates of $335.80 million. On average, analysts expect AdvanSix to post $1 EPS for the current fiscal year and $4 EPS for the next fiscal year.

AdvanSix Price Performance

NYSE:ASIX opened at $25.89 on Friday. AdvanSix has a 52 week low of $23.92 and a 52 week high of $40.85. The firm has a market cap of $691.26 million, a price-to-earnings ratio of 13.63 and a beta of 1.73. The firm’s 50-day simple moving average is $27.30 and its 200 day simple moving average is $27.27. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.58 and a current ratio of 1.17.

AdvanSix Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 18th. Investors of record on Monday, March 4th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.47%. The ex-dividend date was Friday, March 1st. AdvanSix’s dividend payout ratio is 33.68%.

Insiders Place Their Bets

In other AdvanSix news, CEO Erin N. Kane sold 1,385 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $27.96, for a total transaction of $38,724.60. Following the sale, the chief executive officer now directly owns 556,370 shares in the company, valued at $15,556,105.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, CEO Erin N. Kane sold 1,385 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $27.96, for a total value of $38,724.60. Following the sale, the chief executive officer now directly owns 556,370 shares in the company, valued at approximately $15,556,105.20. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Erin N. Kane sold 3,002 shares of the firm’s stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $28.08, for a total transaction of $84,296.16. Following the completion of the sale, the chief executive officer now owns 552,755 shares in the company, valued at $15,521,360.40. The disclosure for this sale can be found here. Insiders have sold 17,387 shares of company stock worth $486,481 over the last ninety days. Corporate insiders own 5.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Stifel Nicolaus reaffirmed a “buy” rating and set a $40.00 price target on shares of AdvanSix in a research report on Tuesday, April 9th.

About AdvanSix

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.